ANDREW RENZI: Open Payments
NPI 1225709868 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 52 payments from 24 companies in 2025. Trend: 2023 $3,653 · 2024 $4,520 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $183 |
| ABBVIE INC. | 12 | $137 |
| Collegium Pharmaceutical, Inc. | 5 | $97 |
| Astellas Pharma US Inc | 3 | $76 |
| Aimmune Therapeutics, Inc. | 3 | $75 |
| Novo Nordisk Inc | 3 | $69 |
| SHIELD THERAPEUTICS INC | 1 | $58 |
| Braeburn Inc. | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $26 |
Products named: Auvelity, Jornay PM, Veozah, ZENPEP, UBRELVY, ACCRUFER, REXULTI, BRIXADI.
Industry payments across PA — which companies pay providers there.
